Animal Healthcare Market is expected to witness the fastest growth in Asia-Pacific

Posted on 2019-08-15 by P&S Intelligence in Consumer Services, Healthcare // 0 Comments

Animal Healthcare Market

Animal healthcare market is expected to reach $42,926.7 million by 2023, according to P&S Intelligence.

The growth in the market can be attributed to the increasing consumption of milk and meat, rising adoption of companion animals, and increasing prevalence of food-borne zoonotic diseases.

Based on product, the market is classified into feed additives, vaccines, anti-infectives, anti-inflammatories, parasiticides, and others, wherein “others” include oncological and antiemetic products, drugs for reproductive problems, and sedatives for pain relief. Among these, the category of feed additives held the largest share in the animal healthcare market in 2017. Increasing consumption of animal-derived products and rising feed production are the key factors driving the market growth of this category.

Based on distribution channel, the market is classified into veterinary hospitals, veterinary clinics, pharmacies and drug stores, and others, wherein “others” include online and retail stores. Of these, veterinary hospitals held the largest share in the global animal healthcare market in 2017. As compared to veterinary clinics, veterinary hospitals provide complete animal healthcare services for animals, including accommodation and nursing care, due to which a large number of pet owners prefer taking their animals to these hospitals.

Geographically, the animal healthcare market is projected to witness the fastest growth in APAC during the forecast period. China is anticipated to be the fastest-growing market globally during 2018–2023, followed by India and Brazil. Growing livestock population and increasing demand for animal-source food products are some of the key factors driving the market in the country. Also, China was the world’s largest livestock producer and consumer in 2016, with more than 400 million cattle, sheep, and goats.

Discovery of animal diseases is expected to offer lucrative opportunities to medicine-manufacturing companies

With increasing animal population and rising incidence of diseases in animals, there has been a rise in the development of medicines for inhibiting the growth of diseases in animals. A lot of animal diseases are reported every year, which offer opportunities to companies in the animal healthcare market for product development. Diseases such as the Nipah virus (NiV) infection, melioidosis, bluetongue, and porcine reproductive and respiratory syndromes are commonly reported in animals. Hence, companies in the market are actively working toward the development of medicines that would help reduce the spread of such diseases.

Animal Healthcare Market – Competitive Landscape

The intensity of rivalry among players in the animal healthcare market is moderate. Most of the major players are actively focusing on partnerships, and mergers and acquisitions to meet the growing demand in the emerging market. For instance, in June 2018, Zoetis Inc., a key market player, and Regeneron Pharmaceuticals Inc., a biotechnology company that develops medicines for critical animal diseases, announced a five-year collaboration to study the use of monoclonal antibody therapeutics in animals.

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Matched content

Editor’s pick